In this study, we demonstrated that, in myeloma cells, ART treatment inhibited nuclear localization of SREBP2 and induced ferroptosis through the SREBP2-IPP-GPX4 axis, thereby inhibiting proliferation. Here, GPX4 is linked to plasma cell myeloma.